elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33880165-852D638C-CD0C-443C-9411-5BD3FAE26B3D
Q33880165-852D638C-CD0C-443C-9411-5BD3FAE26B3D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33880165-852D638C-CD0C-443C-9411-5BD3FAE26B3D
Trial watch: Immunostimulatory cytokines in cancer therapy.
P2860
Q33880165-852D638C-CD0C-443C-9411-5BD3FAE26B3D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33880165-852D638C-CD0C-443C-9411-5BD3FAE26B3D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1daa14dba7744a664df1eaeeefc489991095c3e4
P2860
IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients.